The Value Signal — July 24, 2026

649 articles scanned · 14 high-signal

Signal Map

Executive Summary

Washington is tightening the economics of value-based care from every angle: MSSP benchmarks, MA stars, Medicaid financing, and fraud enforcement are all moving from growth-era flexibility to hard-edged accountability.

Medicare risk and performance economics are being reset. CMS has proposed major CY 2027 MSSP financial changes that could create new ACO opportunities while materially affecting benchmark calculations and shared savings, Wakely reports. In ACO REACH, Empassion generated $60 million in cost savings, Hospice News reports, while CMS is appealing Clover’s Medicare Advantage star-ratings lawsuit over recalculation of its ratings, Healthcare Dive reports. Humana is cutting Medicare Advantage plan availability to 85% of U.S. counties for 2027, Newsbreak reports, reinforcing that MA and ACO operators are now optimizing footprint, ratings, and benchmarks with far less tolerance for marginal economics.

Administrative friction, Medicaid financing, and enforcement risk are rising in parallel. Prior authorization remains a major provider-trust issue for Aetna, Healthcare Brew reports, while CMS is laying groundwork for further OBBBA-related provider-tax cutbacks, Fierce Healthcare reports, and the political fight over Medicaid deferrals is heightening risk for home care, Home Health Care News reports. Risk adjustment remains a live operational pressure point for coding and compliance teams, AAPC reports, and a medical supply company owner was convicted in a $30 million Medicare fraud scheme, HHS OIG reports, underscoring that VBC margin strategy now has to withstand both actuarial scrutiny and enforcement scrutiny.